December 2025 – Published Articles

Correction: Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy.
Iida M, Brand TM, Starr MM, Huppert EJ, Luthar N, Bahrar H, Coan JP, Pearson HE, Salgia R, Wheeler DL.Mol Cancer. 2025 Dec 30;24(1):312. doi: 10.1186/s12943-025-02531-3.PMID: 41462474 Free PMC article. No abstract available.

Dosimetric characterization of the Xoft Axxent electronic brachytherapy source: A Monte Carlo study.
Khan AU, Walter AE, DeWerd LA.Brachytherapy. 2025 Dec 23:S1538-4721(25)00359-9. doi: 10.1016/j.brachy.2025.11.003. Online ahead of print.PMID: 41444097

Establishing a global medical physics graduate clinical training and development program in Ghana: A model for global health international education and collaboration.
O’Reilly SE, Avery S, Dinh L, Friberg A, Okuribido A, Addison EK, Inkoom S, Baidoo AM, Tagoe SN, Kaufmann EE, Gwak S, Doherty ML, Sosu E, Addai BW, Hasford F.J Appl Clin Med Phys. 2025 Dec;26(12):e70410. doi: 10.1002/acm2.70410.PMID: 41395828 Free PMC article.

Multiinstitutional survey of source modeling parameters for proton pencil beam scanning treatment planning system commissioning.
Charyyev S, Maradia V, Chang CW, Lin L, Dong L, Li H, Schuemann J, Shen J, Kang M, Taylor P, Zhang Y, Tang S, Wang P, Freund D, Zhang H, Zhao T, Chang C, Chen CC, Pankuch M, Gao M, Yu F, Lin H, Li Z, Wong T, Regmi R, Poels K, Depuydt T, Liu H, Broekhoven BL, Mossahebi S, Yi B, Paxton AB, Matsuura T, Wang Z, Vilches-Freixas G, Lin Y, Kurucz S, Ding X.Med Phys. 2025 Dec;52(12):e70199. doi: 10.1002/mp.70199.PMID: 41389057

Combined innate immune cell therapy, tumor-specific antibody, and radiation prompt antitumor response in pancreatic cancer models.
Rahman MM, Pennati A, Atajanova T, Debnath T, Allawi RH, Meyers RO, Berg TJ, Gurel Z, Uboha NV, Bassetti MF, Mao L, Sondel PM, Kimple RJ, Capitini CM, Sodji QH, Galipeau J, Morris ZS.Sci Adv. 2025 Dec 5;11(49):eadx2984. doi: 10.1126/sciadv.adx2984. Epub 2025 Dec 5.PMID: 41348892 Free PMC article.

Cisplatin during radiation for head and neck cancer: insights from NRG Oncology experience.
Sousa LG, Edward Bates J, Anand P, Caudell JJ, Colevas AD, Runge CL, Sharon JD, Awan M, Beadle BM, Choe JH, Gidley PW, Harari PM, Henson C, Katzel JA, Lee NY, Mcdowell L, Mell LK, Nader ME, Rudra S, Wang K, Yang G, Yom SS, Wise-Draper TM.J Natl Cancer Inst. 2025 Dec 4:djaf343. doi: 10.1093/jnci/djaf343. Online ahead of print.PMID: 41344314

Proton pencil beam scanning ultra-high dose rate 3D lattice radiotherapy: A proof-of-concept FLASH SFRT study.
Wei S, Qi H, Xu L, Selvaraj B, Zhao X, Zheng A, Vermeulen M, Lee NY, Bakst R, Guha C, Tsai P, Kang M, Wu X, Yacoub I, Choi JI, Chhabra A, Simone CB 2nd, Lin H.Med Phys. 2025 Dec;52(12):e70187. doi: 10.1002/mp.70187.PMID: 41330730

IFNγ and TNFα optimize salivary gland mesenchymal stromal cells: an alternative to marrow- and adipose-MSCs for radiation xerostomia.
Larsen MC, Gurevic I, Berube L, Vande Loo A, Hanson E, Adam R, Manfrè V, Parker M, Paz C, Galipeau J, Kimple RJ, Blitzer G, McCoy SS.Regen Ther. 2025 Nov 14;30:1086-1100. doi: 10.1016/j.reth.2025.11.004. eCollection 2025 Dec.PMID: 41323369 Free PMC article.

Cherenkov emission in realistic optical body phantoms to study effects of skin tone on imaging delivery technique.
Hallett JE, Kulkarni S, Parks A, Crosby J, Glide-Hurst C, Wudtke J, Ware W, Pogue BW.Phys Med Biol. 2025 Dec 5;70(23):235036. doi: 10.1088/1361-6560/ae237d.PMID: 41285108 Free PMC article.

Assessing the potential and pitfalls of spot sequence optimization for OAR-specific dose rate control in proton PBS Bragg peak FLASH radiotherapy.
Diao L, Zhao X, Cheng C, Zhang T, Wei S, Meng D, Wei Z, Ma Y, Zhu K, Wu H, Durkee B, Lin H, Simone CB, Yan X, Kang M.Radiother Oncol. 2026 Jan;214:111291. doi: 10.1016/j.radonc.2025.111291. Epub 2025 Nov 19.PMID: 41271173